CG
ELV icon

Cynosure Group’s Elevance Health ELV Stock Holding History

Cynosure Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-856
Closed -$277K – 447
2025
Q3 		$277K Hold
856
– – 0.03% 354
2025
Q2 		$333K Hold
856
– – 0.04% 355
2025
Q1 		$372K Sell
856
-4,879
-85% -$1.96M 0.05% 187
2024
Q4 		$2.12M Buy
5,735
+4,968
+648% +$2.08M 0.32% 44
2024
Q3 		$399K Buy
767
+49
+7% +$26.2K 0.06% 206
2024
Q2 		$389K Buy
718
+97
+16% +$51.3K 0.06% 217
2024
Q1 		$322K Buy
+621
New +$309K 0.06% 228

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Cynosure Group's ELV Position: Q4 2025 in Review

Cynosure Group sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 856 shares — an estimated $277K sold.

Cynosure Group first reported a position in ELV in Q1 2024 and held it in 7 quarters. The position peaked at $2.12M in Q4 2024. 1,553 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Cynosure Group reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • Cynosure Group sold 856 Elevance Health shares in Q4 2025, an estimated $277K.
  • Cynosure Group first reported a position in Elevance Health in Q1 2024 and held it in 7 quarters.
  • Cynosure Group's Elevance Health position peaked at $2.12M in Q4 2024.
  • 1,553 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Cynosure Group's 13F filing for Q4 2025, filed 17 Feb 2026.